Laurie Stelzer insider trades
Open-market stock purchases and sales by Laurie Stelzer, Director at Sionna Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | SION Sionna Therapeutics, Inc | Bought (not open market) | — |
| Jun 4, 2026 | PMVP PMV Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 4, 2026 | MBX MBX Biosciences, Inc | Bought (not open market) | — |
| May 27, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
| Jan 20, 2026 | MBX MBX Biosciences, Inc | Bought (not open market) | — |
Companies traded
- SION Sionna Therapeutics, Inc: other filings, last Jun 17, 2026
- PMVP PMV Pharmaceuticals, Inc: other filings, last Jun 4, 2026
- MBX MBX Biosciences, Inc: other filings, last Jun 4, 2026
- SYRE Spyre Therapeutics, Inc: other filings, last May 27, 2026
- AGLE Spyre Therapeutics, Inc: other filings, last Nov 22, 2023
- MRTX Mirati Therapeutics, Inc: 1 sale, last Aug 9, 2023
- SURF Surface Oncology, Inc: other filings, last Jun 8, 2022
- ARNA Arena Pharmaceuticals Inc: other filings, last Mar 11, 2022
- HALO Halozyme Therapeutics, Inc: 2 buys, last Feb 22, 2020